Repertoire Immune Medicines Partners with Lilly to Innovate Autoimmune Disease Therapies Repertoire Immune Medicines has teamed up with Eli Lilly to develop groundbreaking therapies for autoimmune diseases, aiming for effective treatments without general immune suppression.

Repertoire Immune Medicines Partners with Lilly to Innovate Autoimmune Disease Therapies #USA #Cambridge #Lilly #Autoimmune_Diseases #Repertoire_Immune

Repertoire Immune Medicines Welcomes Dr. Robert Andtbacka as New Chief Medical Officer Repertoire Immune Medicines appoints Dr. Robert Andtbacka as CMO, enhancing leadership as they advance a promising TCR bispecific therapy into clinical trials.

Repertoire Immune Medicines Welcomes Dr. Robert Andtbacka as New Chief Medical Officer #United_States #Cambridge #Repertoire_Immune #Robert_Andtbacka #TCR_Bispecific

Repertoire Immune Medicines and Genentech Form Partnership to Innovate Autoimmune Treatments Repertoire Immune Medicines teams up with Genentech to develop innovative T cell-targeted therapies for autoimmune diseases, utilizing their advanced DECODE™ platform.

Repertoire Immune Medicines and Genentech Form Partnership to Innovate Autoimmune Treatments #USA #Cambridge #T_Cell_Therapy #Repertoire_Immune #Genentech